CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- Open-market buys, last 90 days
- $49,118
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,118. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-31 | DO CUONG V President & CEO | Grant or award | +21,710 | 58,759 | ||
| 2021-12-07 | KIM JOANNE WENDY CFO | Purchase | +2,000 | $5.40 | $11K | 2,000 |
| 2021-08-20 | READING CHRISTOPHER EVP Neuroscience R&D | Grant or award · Stock Option (right to buy) | +124,167 | 124,167 | ||
| 2021-08-20 | Ahlem Clarence N. EVP Neuroscience Product Dev. | Grant or award · Stock Option (right to buy) | +124,167 | 124,167 | ||
| 2021-08-20 | Do Cuong V CEO & President | Grant or award · Stock Option (right to buy) | −745,000 | 745,000 | ||
| 2021-08-20 | MARKHAM PENELOPE EVP Liver Cirrhosis R&D | Grant or award · Stock Option (right to buy) | −124,167 | 124,167 | ||
| 2021-08-20 | Adams Jonathan M EVP Liver Cirrhosis Programs | Grant or award · Stock Option (right to buy) | −124,167 | 124,167 | ||
| 2021-08-20 | KIM JOANNE WENDY Chief Financial Officer | Grant or award · Stock Option (right to buy) | −124,167 | 124,167 | ||
| 2021-06-16 | Adams Jonathan M EVP Liver Cirrhosis Programs | Gift | −10,000 | 49,630 | ||
| 2021-06-10 | PEIZER TERREN S Director | Grant or award | +8,361,308 | 19,529,846 | ||
| 2020-12-18 | BERMAN RICHARD J Director | Grant or award · Stock Option (right to buy) | +102,500 | 102,500 | ||
| 2020-12-18 | Hariri Robert J Director | Grant or award · Stock Option (right to buy) | +95,900 | 95,900 | ||
| 2020-12-18 | GORLIN STEVE Director | Grant or award · options | +96,300 | $13.91 | $1.3M | 96,300 |
| 2020-12-18 | Sherman Michael Edward Director | Grant or award · options | +103,100 | $13.91 | $1.4M | 119,906 |
| 2020-12-18 | Lang James Paul Director | Grant or award · options | +99,000 | $13.91 | $1.4M | 120,988 |
| 2020-12-18 | Do Cuong V Director | Grant or award · options | +97,500 | $13.91 | $1.4M | 171,366 |
| 2020-12-18 | ROGICH SIGMUND Director | Grant or award · options | +97,300 | $13.91 | $1.4M | 97,300 |
| 2020-11-03 | GORLIN STEVE Director | Purchase | +2,430 | $7.95 | $19K | 45,100 |
| 2020-10-30 | GORLIN STEVE Director | Purchase | +2,570 | $7.97 | $20K | 42,670 |
| 2020-10-21 | GORLIN STEVE Director | Purchase | +5,000 | $9.19 | $46K | 40,100 |
Page 6 of 10 · 193 trades